I1DX34:BVMF
Idexx Laboratories Inc Bdr
516,36 BRL
0,00%
(0,00) 1 D.
10-09, 16:56:00 GMT−3 · BRL
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „I1DX34“ įžvalgos...
Atidaryti
516,36 BRL
Aukšta
516,36 BRL
Žema
516,36 BRL
Rinkos kapitalizacija
40,81 mlrd.
Vid. kiekis
6,00
Apimtis
5,00
52 sav. aukšta
813,60 BRL
52 sav. žema
509,99 BRL
Neapmokėtos akcijos
78,78 mln.
Darbuotojų skaičius
11 tūkst.
Atidaryti
516,36 BRL
Aukšta
516,36 BRL
Žema
516,36 BRL
Rinkos kapitalizacija
40,81 mlrd.
Vid. kiekis
6,00
Apimtis
5,00
52 sav. aukšta
813,60 BRL
52 sav. žema
509,99 BRL
Neapmokėtos akcijos
78,78 mln.
Darbuotojų skaičius
11 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
Simply Wall Street
·
prieš 1 valandą
SolarEdge Technologies (SEDG) Appoints Gokul Krishnan To Lead North America Growth
The Globe and Mail
·
prieš 35 minutes
Streamex Receives Nasdaq Notice on Minimum Bid Price
Simply Wall Street
·
prieš 1 valandą
GLOBALFOUNDRIES (GFS) Unveils FDX Fusion As Dresden And AI Packaging Plans Advance
Yahoo Finance
·
prieš 8 valandas
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Profilis
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Apie „Idexx Laboratories Inc Bdr“
Generalinis direktoriusJay Mazelsky
Darbuotojai11 tūkst.
Įkurta1983-12-19
Pagrindinė būstinėWestbrook, Meinas, Jungtinės Valstijos
Sektorius-
Svetainėidexx.com